(Q46184125)

English

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis

scientific article

Statements

Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit